The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 07, 2023

Filed:

Dec. 29, 2020
Applicant:

Human Biomolecular Research Institute, San Diego, CA (US);

Inventors:

John R Cashman, San Diego, CA (US);

Daniel R Ryan, San Diego, CA (US);

Sigeng Chen, San Diego, CA (US);

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61L 27/38 (2006.01); A61L 27/12 (2006.01); C07D 215/44 (2006.01); C07D 487/04 (2006.01); A61K 31/519 (2006.01); A61K 33/42 (2006.01); A61K 38/18 (2006.01); A61K 31/4706 (2006.01); A61K 31/12 (2006.01); A61K 45/06 (2006.01); A61K 35/28 (2015.01); A61L 27/28 (2006.01); A61L 27/32 (2006.01); A61L 27/42 (2006.01); A61L 27/54 (2006.01); A61L 27/58 (2006.01); C07C 49/248 (2006.01); C07C 49/255 (2006.01); C07C 225/22 (2006.01); G01N 33/50 (2006.01); C07C 229/40 (2006.01); C12Q 1/6883 (2018.01);
U.S. Cl.
CPC ...
A61L 27/3895 (2013.01); A61K 31/12 (2013.01); A61K 31/4706 (2013.01); A61K 31/519 (2013.01); A61K 33/42 (2013.01); A61K 35/28 (2013.01); A61K 38/18 (2013.01); A61K 45/06 (2013.01); A61L 27/12 (2013.01); A61L 27/28 (2013.01); A61L 27/32 (2013.01); A61L 27/3834 (2013.01); A61L 27/3847 (2013.01); A61L 27/425 (2013.01); A61L 27/54 (2013.01); A61L 27/58 (2013.01); C07C 49/248 (2013.01); C07C 49/255 (2013.01); C07C 225/22 (2013.01); C07C 229/40 (2013.01); C07D 215/44 (2013.01); C07D 487/04 (2013.01); C12Q 1/6883 (2013.01); G01N 33/502 (2013.01); G01N 33/5044 (2013.01); A61L 2300/112 (2013.01); A61L 2300/412 (2013.01); A61L 2300/606 (2013.01); A61L 2300/64 (2013.01); A61L 2400/18 (2013.01); A61L 2420/02 (2013.01); A61L 2420/06 (2013.01); A61L 2430/02 (2013.01); A61L 2430/40 (2013.01); C12Q 2600/136 (2013.01); C12Q 2600/158 (2013.01); G01N 2333/916 (2013.01);
Abstract

Compositions of small molecules, matrices, and isolated cells including methods of preparation, and methods for differentiation, trans-differentiation, and proliferation of animal cells into the osteoblast cell lineage were described. Examples of osteogenic materials that were administered to cells or co-cultured with cells are represented by compounds of Formula II, IV, and VI independently or preferably in combination with a matrix to afford bone cells. Small molecule-stimulated cells were also combined with a matrix, placed with a cellular adhesive or material carrier and implanted to a site in an animal for bone repair. Matrix pretreated with compounds of Formula II, IV, and VI were also used to cause cells to migrate to the matrix that is of use for therapeutic purposes.


Find Patent Forward Citations

Loading…